Discovery of allosteric non-covalent KRAS inhibitors that bind with sub-micromolar affinity and disrupt effector binding
Michael J. McCarthy(VA San Diego Healthcare System), Alemayehu A. Gorfe(Texas Medical Center)
Cited by 0
Related Papers
Computational and biochemical characterization of two partially overlapping interfaces and multiple weak-affinity K-Ras dimers
|Scientific Reports|2017|101
Small-Molecule Inhibition of KRAS through Conformational Selection
|ACS Omega|2023|2
MRTX1133 is a potent non-covalent KRAS (G12C) inhibitor with tissue-specific activity
|bioRxiv (Cold Spring Harbor Laboratory)|2025|2